9+ hour, 2+ min ago  (187+ words) 19 May 2026 | Tuesday | News This expanded collaboration extends beyond manufacturing, bringing together Ottimo Pharma and LOTTE Biologics to advance Ottimo Pharma's promising biparatopic antibody, OTP-01, toward launch readiness. Lotte's development team at the Syracuse Bio Campus in New York, will support…...

2+ hour, 29+ min ago  (329+ words) A domestic bio-technology that uses waste resources to mass-produce eco-friendly plastic and fiber feedstocks has been developed in Korea. The breakthrough is being touted as a future core technology that could eventually replace naphtha in the petrochemical industry. The Korea…...

7+ hour, 35+ min ago  (1032+ words) - Research Describes the Potential of JCR's Platform Technologies, Including JUST-AAV Gene Therapy, to Facilitate Delivery of Therapies to the Central Nervous System -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co. , Ltd. (TSE 4552; "JCR), a global specialty biopharmaceutical company dedicated to developing…...

1+ hour, 6+ min ago  (1150+ words) Invion is tackling a difficult eye disease that defeated Opthea, big time. But will its approach prove to be visionary? Pic: Getty Images Cancer drug developer Invion (ASX: IVX) has turned to the non-oncology ophthalmology sector, via a collaboration to tackle…...

2+ hour, 20+ min ago  (134+ words) Cambridge Sensoriis has announced Mike Hall as its new chief executive officer. He succeeds Dr Steve Clark, who will continue to be involved with Sensoriis as the founder and a board member. Mike Hall was instrumental in delivering Sensoriis" patented…...

23+ hour, 33+ min ago  (254+ words) Regeneron Pharmaceuticals announced that its Phase 3 melanoma trial combining fianlimab and Libtayo did not meet the primary endpoint against Keytruda, causing the stock to fall more than 10%. Prior optimism from company executives about the trial's progress led to significant investor…...

2+ hour, 5+ min ago  (184+ words) The company's lead program targets knee osteoarthritis, a condition affecting more than 32 million Americans. Wonderlab Bio is developing an injectable i PSC-derived chondrocyte therapy aimed at regenerating cartilage without surgery. The company said the treatment is expected to cost less…...

10+ hour, 21+ min ago  (229+ words) Nano Vita will further expand its reach through the collaboration with Claw Intelligence. Claw Intelligence provides an all-encompassing, one-stop trade execution and intelligence service for on-chain activity that has been built directly upon the $BNB smart contract Blockchain. The foundation…...

1+ hour, 21+ min ago  (430+ words) The Crisafulli Government has lured Victoria-based Clinical Trial Group to set up shop in Queensland, investing $11. 2 million through the flagship $180. 6 million Sovereign Industry Development Fund. Clinical Trials Group will expand into Queensland with the establishment of a new 40+ bed Phase…...

13+ hour, 33+ min ago  (832+ words) SHANGHAI, May 18, 2026 /PRNewswire/ " Sanyou Biopharmaceuticals announced today that its independently developed AI-STAL has undergone a significant upgrade, successfully achieving a qualitative leap from "molecular treasure trove" to "intelligent engine", marking the company's entry into a new era of intelligence in…...